乳糖不耐症の世界市場-2023年～2030年

概要

世界の乳糖不耐症市場は、2022年に216億米ドルに達し、2023-2030年の予測期間中にCAGR 7.1％で成長し、2030年には283億米ドルに達すると予測されています。

牛乳やその他の乳製品に含まれる乳糖を消化する能力がないことを乳糖不耐症と言います。乳糖不耐症が発症する年齢は異なります。乳糖不耐症は主に乳幼児に発症しますが、2歳くらいの子供にも発症することがあり、成人にもかなり多くみられます。乳糖不耐症の治療法としては、乳糖を減らした食事、プレバイオティクス、プロバイオティクス、酵素補充などがあります。

しかし、その結果、カルシウム、ビタミンD、リボフラビンなど、人間の健康に不可欠なビタミンや栄養素が不足する可能性があります。無乳糖牛乳や豆乳、ライスミルクなどの代用乳を飲む人もいますが、これらの製品は本物の牛乳の代わりにはなりません。乳糖不耐症は、世界中で約75％の人が罹患しています。食品メーカーは、乳糖不耐症の人のために特別に作られた幅広い商品を提供することで、乳糖不使用の選択肢を求める消費者の需要に応えてきました。これは、牛乳、ヨーグルト、チーズのような乳製品、さらには乳製品を使用した加工食品など、乳糖不使用の製品に当てはまります。

ダイナミクス

製品発売と治療の増加

企業による新規製品の上市や製品認可の増加は、市場の成長を後押しします。例えば、2023年5月23日、dsm-firmenich社から、高い評価を得ているマキシラクト乳糖分解酵素の製品ラインに最新の新製品、マキシラクトネクストが発売されました。この新製品には、現在市販されているラクターゼの中で最も純粋で効果的なものが含まれています。マキシラクト・ネクストは、同量を投与した場合、加水分解時間を25％短縮し、生乳処理に使用される従来の最も迅速な市場標準よりも約25％速くなります。

マキシラクト・ネクストの支援により、無乳糖乳製品メーカーは、生産能力を向上させ、生産を最適化し、原材料をより効果的に使用することができます。さらに、2021年8月には、培養食品会社のグッドカルチャー社から、初の無乳糖ラインや絞り出し可能なサワークリームパウチなど、多くの新鮮な商品が発売されます。

これらの製品には生きた活性培養液が含まれており、中西部の小規模家族経営の牧場で飼育された牛乳を使用しています。グッド・カルチャーの新製品、スクイーザブル・ホールミルク・クラシック・サワークリーム・パウチには、牛乳、クリーム、酵素、生きた活性培養液の4つの原材料が含まれています。このように、新製品の発売と製品認可の増加が市場拡大の原動力となっています。

乳糖不耐症の増加

乳糖不耐症が増加しているという見方は、特にかつて乳製品の消費が少なかった地域における食生活の変化に影響されている可能性があります。乳糖不耐症の人は、世界的に乳製品の多い食生活を送る人が増えるにつれて、自分の症状を自覚し、診断を求めるようになるかもしれないです。したがって、乳糖不耐症の有病率の増加は市場の成長を後押しします。

例えば、NLMに掲載された論文によると、乳糖不耐症は一般的な症状ではあるが、5歳未満の子供に多いです。若年成人やティーンエイジャーが最も頻繁に罹患します。世界中で約65％の人が乳糖不耐症です。いくつかの民族や人種の中で、乳糖不耐症の有病率は異なります。アジア人、ヒスパニック系／ラテン系、アフリカ系アメリカ人が最も経験しやすいのに対し、欧州系アメリカ人は最も少ないです。

乳糖不耐症がより一般的な民族グループでは、乳糖不耐症がより一般的です。一次性乳糖不耐症が最も多く、世界人口の70％に見られるが、すべての症例に症状が出るわけではないです。一方、先天性乳糖不耐症は非常にまれである（現在までに世界で約40例が報告されている）。したがって、乳糖不耐症の増加は市場の成長を加速させると思われます。

乳糖不使用製品のコストは高い

食品であれ他の材料であれ、製品の製造に工程が加わると、一般的に費用が高くなります。一般的な乳製品の生乳を加工する技術の大半は、1つの連続した流れで加工を行うものです。連続した生乳の流れは、加熱されたパイプや金属板を通してポンプで送られ、低温殺菌されます。ラクターゼ酵素を利用して無乳糖牛乳を作る場合、ラクターゼが牛乳中の乳糖をすべて（あるいは少なくとも十分な量）分解できるようになるまで時間がかかります。そのため、コストが上昇し、乳糖牛乳の処理時間が長くなります。市場の成長は、高価格製品によって妨げられることになります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 製品の上市と治療の増加
    • 乳糖不耐症の有病率の上昇
  • 抑制要因
    • 乳糖不使用製品は高価です。
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• ロシア・ウクライナ戦争の影響分析
• DMI意見

第6章 COVID-19分析

第7章 タイプ別

• 一次性
• 二次性
• 先天性
• 発達性

第8章 診断別

• 水素呼気試験
• ブドウ糖血液検査
• 便酸度検査

第9章 販売チャネル別

• オンライン企業ウェブサイト
• オフライン店舗

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• DSM
  • 企業概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な動向
• Kshipra Biotech Private Limited
• Intoleran
• MACLEODS
• Merck KGaA
• Johnson & Johnson Services, Inc
• NOW Foods
• Procter & Gamble
• Chr. Hansen Holding A/S
• Biofermen Private Limited

第13章 付録

Overview

Global Lactose Intolerance Market reached US$ 21.6 billion in 2022 and is expected to reach US$ 28.3 billion by 2030, growing with a CAGR of 7.1% during the forecast period 2023-2030.

The lack of capacity of a person to digest the lactose sugar found in milk or any other dairy product is recognized as lactose intolerance. Ages at which lactose intolerance can develop differ. Lactose intolerance primarily affects infants, although it can also affect children as young as 2 years old and is quite prevalent in adults. Taking a lactose-reduced diet, prebiotics, probiotics, and enzyme replacement are among treatments for lactose intolerance.

However, this may lead to a deficiency in essential vitamins and nutrients including calcium, vitamin D, and riboflavin, which are essential for human health. Some people drink lactose-free milk or milk substitutes like soy or rice milk, but these products are not a substitute for real milk. Lactose intolerance affects around 75% of people worldwide. Food manufacturers have reacted to consumer demand for lactose-free options by providing a wider selection of goods that are especially created for those who are lactose intolerance. This applies to lactose-free forms of dairy products such milk, yogurt, cheese, and even packaged goods that have dairy consumers.

Dynamics

The Increasing of Product Launches and for the Treatment

The rise of novel product launches and product approvals by the companies, helps to boost the market growth. For instance, on May 23, 2023, the most recent addition to its highly-regarded line of Maxilact lactase enzymes, MaxilactNext, has been launched by dsm-firmenich. The new product contains the purest and most effective lactase currently on the market. Maxilact Next reduces the hydrolysis time by 25% when dosed at the same amount, making it around 25% faster than the previous most rapidly market standard used for milk processing.

With the help of Maxilact Next, lactose-free dairy manufacturers can improve capacity, optimize production, and use raw materials more effectively - all without compromising the flavor of lactose-free products. Moreover, in August 2021, a number of fresh items are being introduced by the cultured food company Good Culture, including its first lactose-free line and squeezable sour cream pouches.

The products contain live and active cultures and are created using pasture-raised milk from small family farms in the Midwest. The new Squeezable Whole Milk Classic Sour Cream Pouch from Good Culture contains milk, cream, enzymes, and live and active cultures in addition to the other four ingredients. Thus, the increase in new product launches and product approvals drives the expansion of the market.

The Rise in Prevalence of Lactose Intolerance

The view of an increase in lactose intolerance may be influenced by changes in dietary habits, particularly in regions where dairy consumption used to be low. Those who are lactose intolerance may become more conscious of their symptoms and seek diagnosis as more people globally adopt diets high in dairy products. Therefore, increasing the prevalence of Lactose intolerance will helps to boost the market growth.

For instance, according to an article published in NLM, stated that, although it is a common condition, lactose intolerance is common in children under the age of five. Young adults and teenagers are most frequently affected by it. Approximately 65% of people worldwide are lactose intolerance. Among several ethnic and racial categories, lactose intolerance varies in prevalence. Asians, Hispanics/Latinos, and African Americans are most likely to experience it, whereas European Americans are least likely to.

Lactose non-persistence is more common in ethnic groups where lactose intolerance is more common. The primary variety is the most prevalent; it can be found in up to 70% of the world's population, although not every case occurs symptoms. In contrast, the congenital a range is incredibly uncommon (about 40 cases have been documented globally to date). Thus rise of lactose intolerance will accelerate the market growth.

The Cost of Lactose Free Products are Expensive

Any additional processes in the manufacture of a product, whether it be food or another material, will typically result in higher expenses. The majority of technologies for processing ordinary dairy milk allow for one continuous flow of processing. A continuous flow of raw milk is pumped through heated pipes and metal plates to pasteurize it. When utilizing the lactase enzyme to make lactose-free milk, it takes time for the lactase to be able to break down all of the lactose in the milk (or at least enough of it). This would increase the cost and lengthen the processing time for lactose milk. The growth of the market would be hampered by the high-priced products.

Segment Analysis

The global lactose intolerance market is segmented based on type, diagnosis, distribution channel and region.

Hydrogen Breath Test is the Only Needed for Diagnosis

Lactose intolerance can be identified objectively using the hydrogen breath test. It measures the quantity of hydrogen gas created as a result of undigested lactose, which can assist medical professionals in determining the severity of the disease. The test is simple and non-invasive. It entails consuming a lactose solution and inhaling through a device that analyzes breath for hydrogen levels. Because of this, it is a safer and more comfortable option than more intrusive procedures.

Moreover, while lactose intolerance is the emergence of symptoms as a result of this malabsorption, lactose malabsorption refers to the body's inability to digest lactose. Since not everyone with lactose malabsorption exhibits symptoms, the hydrogen breath test can help distinguish between these two diseases. Depending on the individual, lactose intolerance can range in severity. Healthcare professionals can offer individualized dietary recommendations based on the results of the hydrogen breath test, such as recommending a lactose-restricted diet or suitable lactase supplements. As a result, the test features contribute to the segment growth.

Geographical Penetration

Prevalence of the Diseases in the Region

Due to the high prevalence of lactose intolerance, growing demand for dairy products, and growing public awareness of the digestive and health benefits of lactose-free dairy products in countries like the United States and Canada, the North American region for lactose-free dairy is anticipated to experience healthy growth during the forecast period. Additionally, the market is being driven primarily by the top companies' novel product launches and the rising prevalence of lactose intolerance. The market is expanding largely due to the vegan lifestyle's increasing acceptance.

For instance, on April 19, 2023, the newest addition to the Clover the Rainbow product line developed for children and children at heart is Clover the Rainbow Milk with a Splash of Flavor, according to Clover Sonoma, a third-generation family-owned and -operated dairy and Certified B Corporation. With no or little added sugar, Clover the Rainbow Milk with a Splash of Flavor comes in three traditional favorites: Chocolate, Vanilla, and Strawberry. These new dairy products are a wonderful source of calcium and protein and don't contain any artificial flavors or sweeteners because they are made with 100% USDA organic, 2% lactose-free milk. All of those factors thus boost regional growth.

COVID-19 Impact Analysis

Access to medical care for conditions unrelated to COVID during the pandemic may have been constrained due to the demand on healthcare resources. It may have been difficult for those with lactose intolerance to get the specialist care or dietary recommendations they required. The pandemic's lockdowns and other interruptions may have caused people to alter their eating patterns. If their typical foods were unavailable or if they were isolated, people with lactose intolerance might have found it difficult to maintain a lactose-free diet. Global supply chains were disrupted by the epidemic, which had an impact on the availability of several products, including lactose- and dairy-free substitutes. This might have had an effect on some regions' availability of lactose-free products.

By Type

• Primary
• Secondary
• Congenital
• Developmental

By Diagnosis

• Hydrogen breath test
• Glucose blood test
• Stool acidity test

By Distribution Channel

• Online Companies Websites
• Offline Stores

By Region

• North America
  • U.S.
  • Canada
  • Mexico

• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

• South America
  • Brazil
  • Argentina
  • Rest of South America

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific

• Middle East and Africa

Key Developments

• In June 2022, the launch of lactose-free cow milk has been announced by Provilac, one of India's neo-age premium milk delivery companies that is expanding the fastest. The angel-funded start-up, which now has a 500 million annual turnover, intends to greatly increase its milk supply. With this launch, Provilac hopes to take between 10 and 20 percent of the lactose-free milk market during the following two to three years.
• In January 2022, in order to satisfy South Korea's expanding demand for plant-based meals, Daiya meals, the most popular dairy-free cheese brand in North America and a pioneer of delectable plant-based goods, has announced a new sales and distribution collaboration with Hyundai Green Food. Hyundai Green Food will be in charge of marketing and sales for Daiya's portfolio of premium plant-based foods, which comprises over 15 dairy-free formats such cheeze blocks, shreds, slices, sticks, and cream cheese style spreads.
• In February 2023, a probiotic has been added to new lactose-free milk that Dairy Farmers of America (DFA) and Good Culture have developed to enhance immunological and gastrointestinal health. Probiotic milk from Good Culture is currently available in full and 2% reduced fat varieties. Thanks to its BC30 probiotic, each 12-oz serving contains 1 billion probiotic bacteria, and the milk is a fantastic source of vitamins A and D.

Competitive Landscape

The major global players in the market include: DSM, Kshipra Biotech Private Limited, Intoleran, MACLEODS, Merck KGaA, Johnson & Johnson Services, Inc, NOW Foods, Procter & Gamble, Chr. Hansen Holding A/S, Biofermen Private Limited and among others.

Why Purchase the Report?

• To visualize the global lactose intolerance market segmentation based on type, diagnosis, distribution channel and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of lactose intolerance market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global Lactose Intolerance market report would provide approximately 61tables, 58figures and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Diagnosis
• 3.3. Snippet by Distribution Channel
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. The increasing of product launches and for the treatment
    • 4.1.1.2. The rise in prevalence of Lactose intolerance
• 4.2. Restraints
  • 4.2.1.1. The cost of lactose free products are expensive
  • 4.2.2. Opportunity
  • 4.2.3. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Russia-Ukraine War Impact Analysis
• 5.6. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. Primary *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Secondary
• 7.4. Congenital
• 7.5. Developmental

8. By Diagnosis

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis
  • 8.1.2. Market Attractiveness Index, By Diagnosis
• 8.2. Hydrogen breath test *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Glucose blood test
• 8.4. Stool acidity test

9. By Distribution Channel

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.1.2. Market Attractiveness Index, By Distribution Channel
• 9.2. Online Companies Websites *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Offline Stores

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. DSM *
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Kshipra Biotech Private Limited
• 12.3. Intoleran
• 12.4. MACLEODS
• 12.5. Merck KGaA
• 12.6. Johnson & Johnson Services, Inc
• 12.7. NOW Foods
• 12.8. Procter & Gamble
• 12.9. Chr. Hansen Holding A/S
• 12.10. Biofermen Private Limited

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us